Molecular Templates, Inc

(NASDAQ:MTEM)

Latest On Molecular Templates, Inc (MTEM):

Date/Time Type Description Signal Details
2023-05-16 02:21 ESTNewsMolecular Templates GAAP EPS of $0.19, revenue of $36.6MN/A
2023-03-31 07:43 ESTNewsMolecular Templates GAAP EPS of -$0.39 misses by $0.09, revenue of $2.6M misses by $6.21MN/A
2023-03-09 19:41 ESTNewsMolecular Templates wins FDA nod to study Tregs-targeting tumor candidateN/A
2022-11-10 20:13 ESTNewsMolecular Templates GAAP EPS of -$0.44 beats by $0.04, revenue of $4.24M beats by $1.16MN/A
2022-08-12 05:21 ESTNewsMolecular Templates GAAP EPS of -$0.44 misses by $0.01, revenue of $4.42M misses by $2.6MN/A
2022-05-12 20:44 ESTNewsMolecular Templates GAAP EPS of -$0.38 beats by $0.04, revenue of $8.49M beats by $3.35MN/A
2022-03-29 05:22 ESTNewsMolecular Templates GAAP EPS of -$0.18 beats by $0.16, revenue of $18M beats by $2.97MN/A
2022-03-17 15:58 ESTNewsMolecular Templates (MTEM) Investor Presentation - slideshowN/A
2021-11-19 16:17 ESTNewsWarning: MTEM is at high risk of performing badlyN/A
2021-11-18 19:14 ESTNewsMolecular Templates gains 8% on FDA Fast Track tag for MT-6402N/A
2021-11-15 08:53 ESTNewsMolecular Templates EPS misses by $0.19, misses on revenueN/A
2021-10-18 18:01 ESTNewsVertex ends agreement with Molecular Templates for conditioning regimensN/A
2021-09-27 21:46 ESTNewsMolecular Templates (MTEM) presents at 2021 Oppenheimer Healthcare ConferenceN/A
2021-09-25 06:21 ESTNewsMolecular Templates up 13% following large share purchase from Swiss investment firmN/A
2021-09-25 06:21 ESTNewsMatinas BioPharma, Dynavax top weekly healthcare gainers; InnovAge, BeyondSpring trailN/A
2021-08-12 20:57 ESTNewsMolecular Templates EPS beats by $0.56, misses on revenueN/A
2021-07-21 15:56 ESTNewsMolecular Templates starts dosing in early-stage MT-6402 cancer studyN/A
2021-04-21 21:59 ESTNewsIntuitive Surgical upgraded after earnings beat; Oppenheimer sizes up new Vertex – CRISPR deal, and more in today’s analyst actionN/A
2021-04-21 21:57 ESTNewsMolecular Templates has a ‘unique’ platform in oncology: BofAN/A
2021-04-06 06:09 ESTNewsMolecular Templates drops 25% on discontinuation of lead asset in lymphoma (updated)N/A
2021-04-05 12:03 ESTNewsMolecular Templates drops 25% on discontinuation of lead asset in lymphomaN/A
2021-04-01 00:48 ESTNewsOur Take On Molecular TemplatesN/A
2021-03-18 22:53 ESTNewsMolecular Templates EPS misses by $0.14, misses on revenueN/A
2021-02-18 00:28 ESTNewsMolecular Templates under pressure on stock offeringN/A
2021-02-11 10:01 ESTNewsMTEM rises on multi-target collaboration with BMY for development of next-gen treatment of cancerN/A
2021-02-04 00:17 ESTAnalyst RatingThe Analyst Target Price has decreased from $20.14 to $19.25.Neutral
2021-01-19 15:12 ESTNewsMolecular Templates to start testing MT-6402 in PD-L1-positive solid tumors patientsN/A
2021-01-06 16:14 ESTFinancialsCompany financials have been released.Neutral
2020-12-22 05:54 ESTNewsMolecular Templates updates on study of MT5111, plans breast cancer expansion cohort in 1H21N/A
2020-11-26 20:53 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 14:17 ESTNewsMolecular Templates: Progress Stalled As Partial Hold Placed On Pivotal ETB TrialN/A
2020-11-10 04:30 ESTFinancialsCompany financials have been released.Neutral
2020-11-10 04:29 ESTAnalyst RatingThe Analyst Target Price has decreased from $21.29 to $20.14.Neutral
2020-11-09 12:43 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 04:38 ESTEarnings EstimateAn EPS average of -$0.47 is estimated for the quarter ending on March 31, 2021.N/A
2020-11-09 04:38 ESTAnalyst RatingThe Analyst Target Price has decreased from $23.14 to $21.29.Neutral
2020-11-07 16:32 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 13:56 ESTNewsMolecular Templates EPS beats by $0.08, misses on revenueN/A
2020-11-04 15:40 ESTInsider TradeTARGET N V BIOTECH has directly acquired 80,000 shares and currently holds 5,229,996 shares.Buy
2020-11-04 15:40 ESTInsider TradeTARGET N V BIOTECH has directly acquired 80,000 shares and currently holds 5,149,996 shares.Buy
2020-09-26 13:27 ESTFinancialsCompany financials have been released.Neutral
2020-09-18 16:43 ESTInsider TradeSHV Management Services, LLC has disposed of 500,000 shares indirectly via Held Sante Health Ventures I, L.P..Sell
2020-09-18 16:43 ESTInsider TradeKEVIN M. LALANDE has disposed of 500,000 shares indirectly via Held Sante Health Ventures I, L.P..Sell
2020-09-17 05:34 ESTFinancialsCompany financials have been released.Neutral
2020-09-09 13:06 ESTAnalyst RatingThe Analyst Target Price has decreased from $23.5 to $23.14.Neutral
2020-09-01 21:11 ESTFinancialsCompany financials have been released.Neutral
2020-09-01 19:54 ESTInsider TradeLongitude Capital Partners III, LLC has indirectly disposed of 2,447 shares.Sell
2020-08-14 09:31 ESTFinancialsCompany financials have been released.Neutral
2020-08-10 09:18 ESTFinancialsCompany financials have been released.Neutral
2020-08-10 09:18 ESTAnalyst RatingThe Analyst Target Price has increased from $22 to $23.5.Buy

About Molecular Templates, Inc (MTEM):

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other diseases. Its proprietary drug platform technology is engineered toxin bodies. The company's lead drug candidate is MT-3724 that is in a Phase II clinical trial for the treatment of relapsed and refractory diffuse large B-cell lymphoma; and Phase II clinical trial for treating non-Hodgkin's lymphoma. It also develops MT-4019, engineered toxin body targeting CD38; and TAK-169 targeting CD38. The company has an agreement with Takeda Pharmaceutical Company Limited to develop CD38-targeted engineered toxin bodies for the treatment of patients with diseases, such as multiple myeloma; and a strategic research collaboration with Vertex Pharmaceuticals Incorporated to discover and develop novel targeted conditioning regimens to enhance the hematopoietic stem cell transplant process; and Bristol Myers Squibb to discover and develop multiple novel therapies designed for specific oncology targets. Molecular Templates, Inc. is headquartered in Austin, Texas.

MTEM Quotes by TradingView

See Advanced Chart

General

  • Name Molecular Templates, Inc
  • Symbol MTEM
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 228
  • Last Split Factor1:11
  • Last Split Date2017-08-02
  • Fiscal Year EndDecember
  • IPO Date2005-02-04
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.mtem.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 29.51
  • Price/Book (Most Recent Quarter) 8.31
  • Enterprise Value Revenue 28.47
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.53
  • Operating Margin -424%
  • Return on Assets -43%
  • Return on Equity -134%
  • Revenue 21.55 million
  • Earnings Per Share -$0.79
  • Revenue Per Share $0.48
  • Gross Profit -28249000
  • Quarterly Earnings Growth 18.8%
View More

Highlights

  • Market Capitalization 658.7 million
  • EBITDA -26519000
  • PE Ratio -1.38
  • Analyst Target Price $19.25
  • Book Value Per Share $1.69
View More

Share Statistics

  • Shares Outstanding 55.96 million
  • Shares Float 37.93 million
  • % Held by Insiders 2342%
  • % Held by Institutions 81.99%
  • Shares Short 1.05 million
  • Shares Short Prior Month 1.19 million
  • Short Ratio 2.2
  • Short % of Float 4%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 1.34
  • 52 Week High $18.44
  • 52 Week Low $7.51
  • 50 Day Moving Average 12.02
  • 200 Day Moving Average 10.75
View More

Dividends

  • Dividend Date 2017-08-02
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Molecular Templates, Inc (MTEM) Dividend Calendar:

MTEM's last dividend payment was made to shareholders on August 2, 2017.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Molecular Templates, Inc (MTEM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$N/A-$0.47-$0.5514.81%
2020-06-302020-08-06$N/A-$0.68-$0.36-88.89%
2020-03-312020-05-11$4.14 million-$0.48-$0.27-80.45%
2019-12-312020-03-12$6.2 million-$0.41-$0.22-84.27%
2019-09-302019-11-12$3.62 million-$1.03-$0.23-357.78%
2019-06-302019-08-12$5.45 million-$0.25-$0.24-6.11%
2019-03-312019-05-13$7.01 million-$0.17-$0.2222.09%
2018-12-312019-03-28$4.68 million-$0.18-$0.2528%
2018-09-302018-11-13$6.75 million-$0.19-$0.3544.93%
2018-06-302018-08-09$1.37 million-$0.36-$0.25-44%
2018-03-312018-05-14$482000-$0.32-$0.25-28%
2017-12-312018-03-28$-253000-$0.26-$0.20-30%
2017-09-302017-11-14$648000-$0.62-$0.15-313.33%
2017-06-302017-07-31$3 million$0.77-$0.77200%
2017-03-312017-05-15$1.89 million-$14.63-$0.82-1684.15%
2016-12-312017-03-27$1.88 million-$0.55-$0.8132.1%
2016-09-302016-11-07$N/A-$0.88-$0.935.38%
2016-06-302016-08-01$N/A-$1.10-$1.100%
2016-03-312016-05-05$N/A-$1.21-$0.22-450%
2015-12-312016-03-10$65.87 million$9.46-$1.34805.97%
2015-09-302015-11-02$3.68 million-$0.99-$1.4833.11%
2015-06-302015-07-30$3.68 million-$0.12-$0.1414.29%
2015-03-312015-04-30$3.68 million-$0.17-$0.13-30.77%
2014-12-312015-03-03$3.68 million-$0.09-$0.1330.77%
2014-09-302014-11-03$3.68 million-$0.13-$0.12-8.33%
2014-06-302014-08-01$3.68 million-$0.11-$1.4392.31%
2014-03-312014-05-01$3.68 million-$1.32-$1.12-17.86%
2013-12-312014-03-06$3.21 million-$1.43-$1.12-27.68%
2013-09-302013-11-04$3.18 million$0.22-$1.58113.92%
2013-06-302013-08-01$3.18 million-$2.42-$1.56-55.13%
2013-03-312013-05-02$2.92 million-$1.76-$0.97-81.44%
2012-12-312013-03-07$2.02 million$5.50-$1.04628.85%
2012-09-302012-11-02$1.8 million-$0.22-$0.6264.52%
2012-06-302012-08-02$1.8 million$3.41-$1.18388.98%
2012-03-312012-05-03$252000-$1.65$1.50-210%
2011-12-312012-03-08-$1.21-$1.5823.42%
2011-09-302011-11-03$N/A-$0.88-$1.6546.67%
2011-06-302011-08-04$N/A-$1.76-$1.791.68%
2011-03-312011-05-12-$2.20-$1.94-13.4%
2010-12-312011-03-24-$2.09-$2.205%
2010-09-302010-11-04-$1.98-$2.2010%
2010-06-302010-08-05-$0.11-$1.9894.44%
2010-03-312010-05-07-$1.98-$1.980%
2009-12-312010-03-04-$1.65-$1.9816.67%
2009-09-302009-11-05-$4.40-$4.624.76%
2009-06-302009-08-06-$4.51-$3.74-20.59%
2009-03-312009-05-07-$4.73-$3.63-30.3%
2008-12-312009-03-05-$3.47
2008-09-302008-11-06-$5.39-$3.96-36.11%
2008-06-302008-08-07-$7.26-$9.2421.43%
2008-03-312008-05-08-$8.80
2007-12-312008-03-06-$13.14
2007-09-302007-11-07-$11.88-$11.880%
2007-06-302007-08-07-$13.86-$20.1331.15%
2007-03-312007-05-09-$16.50-$14.52-13.64%
2006-12-312007-03-07-$17.16-$27.5537.71%
2006-09-302006-11-08-$30.36-$29.17-4.08%
2006-06-302006-08-09-$28.38-$26.95-5.31%
2006-03-312006-05-10-$25.08-$29.0413.64%
2005-12-312006-03-01-$29.04-$22.44-29.41%
2005-09-302005-11-10-$26.40-$24.86-6.19%
2005-06-302005-08-10-$23.76-$17.82-33.33%
2005-03-312005-05-02-$30.46
2004-12-312005-03-01-$202.51

Molecular Templates, Inc (MTEM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development N/A N/A 20.63 million N/A N/A
Income Before Tax N/A N/A -22.01 million -15.88 million -38.22 million
Selling General Administrative N/A N/A 5.65 million 6.03 million 4.51 million
Gross Profit N/A N/A N/A -10.38 million -11.63 million
Ebit N/A N/A -21.05 million -16.4 million -16.14 million
Operating Income N/A N/A -22.14 million -16.4 million -16.14 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A 4.14 million 6.2 million 3.62 million
Cost of Revenue N/A N/A N/A 16.57 million 15.25 million
Total Other Income Expense Net N/A N/A N/A 522000 -22.08 million
Net Income From Continuing Operations N/A N/A -22.02 million -15.88 million -38.22 million
Net Income Applicable to Common Shares -23.23 million -31.23 million N/A -15.88 million -38.22 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments -21.52 million N/A -32.95 million N/A 19.59 million
Change to Liabilities -921000 -6.15 million N/A N/A -3.37 million
Total Cash Flow from Investing Activities -22.59 million 7.67 million N/A N/A 14.38 million
Net Borrowings N/A 9.69 million N/A N/A 31000
Total Cash Flow from Financial Activities 48.62 million N/A 93000 N/A 484000
Change to Operating Activities N/A 6.27 million N/A N/A 2.32 million
Change in Cash 6.21 million N/A -51.01 million N/A -1.53 million
Total Cash from Operating Activities -19.82 million -24.32 million -18.15 million N/A -16.39 million
Depreciation 1.34 million N/A 618000 N/A 350000
Other Cash Flow from Investing Activities 15000 N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A -1.26 million
Other Cash Flow from Financing Activities -3000 7000 N/A N/A N/A
Change to Net Income 3.29 million 4.29 million N/A N/A 23.67 million
Capital Expenditures 1.08 million N/A 938000 N/A 5.21 million
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities N/A N/A 76.98 million 71.17 million 40.15 million
Total Stockholder Equity N/A N/A 83.77 million 103.03 million 53.02 million
Other Current Liabilities 24.6 million N/A 10.3 million 19.79 million 12.59 million
Total Assets N/A N/A 160.74 million 174.2 million 93.16 million
Common Stock 50000 46000 N/A 46000 37000
Other Current Assets 4.75 million N/A 242000 4.99 million 4.8 million
Retained Earnings -240.6 million -217.37 million -186.14 million -164.13 million -148.24 million
Other Liabilities 16.89 million 19.66 million N/A 20.75 million 2.47 million
Other Assets 5.24 million 4.84 million N/A 4.68 million 4.74 million
Cash N/A N/A 34.44 million 85.45 million 15.27 million
Total Current Liabilities 40.4 million N/A 43.84 million 35.8 million 24.1 million
Other Stockholder Equity 73000 172000 N/A 18000 20000
Property, Plant & Equipment 32.48 million 29.49 million N/A 28.12 million 24.28 million
Total Current Assets 129.66 million N/A 124.2 million 139.9 million 64.15 million
Long Term Investments N/A N/A 3.01 million 1.51 million N/A
Net Tangible Assets 84.44 million 55.86 million N/A 103.03 million 53.02 million
Short Term Investments N/A N/A 70.54 million 39.63 million 36.15 million
Long Term Debt N/A N/A 2.89 million 2.94 million 3 million
Inventory N/A N/A N/A N/A N/A
Accounts Payable 2.57 million N/A 1.77 million 1.47 million 1.41 million

Molecular Templates, Inc (MTEM) Chart:

Molecular Templates, Inc (MTEM) News:

Below you will find a list of latest news for Molecular Templates, Inc (MTEM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Molecular Templates, Inc (MTEM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest MTEM Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST100$0.92
Jun 13, 2022 7:58 PM EST100$0.92
Jun 13, 2022 7:58 PM EST55$0.9297
Jun 13, 2022 7:58 PM EST100$0.9201
Jun 13, 2022 7:59 PM EST100$0.9298

Molecular Templates, Inc (MTEM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1183765/999999999520001478/9999999995-20-001478-index.htm
2020-06-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1183765/000000000020005328/0000000000-20-005328-index.htm
2020-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1183765/000000000020007381/0000000000-20-007381-index.htm
2017-11-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924317026313/0000899243-17-026313-index.htm
2017-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924317026315/0000899243-17-026315-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924318014898/0000899243-18-014898-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924318014899/0000899243-18-014899-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924318014902/0000899243-18-014902-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924318014905/0000899243-18-014905-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924318014908/0000899243-18-014908-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924318014909/0000899243-18-014909-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924318014914/0000899243-18-014914-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924318014918/0000899243-18-014918-index.htm
2018-06-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924318015559/0000899243-18-015559-index.htm
2018-07-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924318019865/0000899243-18-019865-index.htm
2018-07-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924318019866/0000899243-18-019866-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924318025415/0000899243-18-025415-index.htm
2018-11-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924318029818/0000899243-18-029818-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319004257/0000899243-19-004257-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319004259/0000899243-19-004259-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319004261/0000899243-19-004261-index.htm
2019-02-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319004384/0000899243-19-004384-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319004401/0000899243-19-004401-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319015224/0000899243-19-015224-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319015226/0000899243-19-015226-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319015227/0000899243-19-015227-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319015232/0000899243-19-015232-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319015233/0000899243-19-015233-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319028236/0000899243-19-028236-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319028242/0000899243-19-028242-index.htm
2019-12-054/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319028574/0000899243-19-028574-index.htm
2019-12-054/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319028575/0000899243-19-028575-index.htm
2019-12-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319029721/0000899243-19-029721-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924319029722/0000899243-19-029722-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320000254/0000899243-20-000254-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320004987/0000899243-20-004987-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320004988/0000899243-20-004988-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320004989/0000899243-20-004989-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320004990/0000899243-20-004990-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320014482/0000899243-20-014482-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320014484/0000899243-20-014484-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320014734/0000899243-20-014734-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320014735/0000899243-20-014735-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320014739/0000899243-20-014739-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320014740/0000899243-20-014740-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320014741/0000899243-20-014741-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320014742/0000899243-20-014742-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320023790/0000899243-20-023790-index.htm
2020-11-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320030338/0000899243-20-030338-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000089924320030364/0000899243-20-030364-index.htm
2018-12-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000091957418008210/0000919574-18-008210-index.htm
2019-11-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000091957419007463/0000919574-19-007463-index.htm
2018-10-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1183765/000092189518002688/0000921895-18-002688-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1183765/000092189519000469/0000921895-19-000469-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1183765/000092189520000545/0000921895-20-000545-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1183765/000114420418008419/0001144204-18-008419-index.htm
2018-09-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1183765/000114420418050925/0001144204-18-050925-index.htm
2018-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184318001972/0001171843-18-001972-index.htm
2018-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184318002342/0001171843-18-002342-index.htm
2018-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184318003912/0001171843-18-003912-index.htm
2018-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184318004015/0001171843-18-004015-index.htm
2018-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184318004400/0001171843-18-004400-index.htm
2018-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184318004781/0001171843-18-004781-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184318005952/0001171843-18-005952-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184318007815/0001171843-18-007815-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184318007898/0001171843-18-007898-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184319002044/0001171843-19-002044-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184319003310/0001171843-19-003310-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184319005415/0001171843-19-005415-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184319007467/0001171843-19-007467-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184320001683/0001171843-20-001683-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184320003594/0001171843-20-003594-index.htm
2020-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184320005042/0001171843-20-005042-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184320005681/0001171843-20-005681-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000117184320007679/0001171843-20-007679-index.htm
2018-01-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000119312518004618/0001193125-18-004618-index.htm
2018-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1183765/000119312518041929/0001193125-18-041929-index.htm
2018-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000119312518069021/0001193125-18-069021-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1183765/000119312518143452/0001193125-18-143452-index.htm
2018-05-25S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1183765/000119312518175256/0001193125-18-175256-index.htm
2018-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000119312518200311/0001193125-18-200311-index.htm
2018-06-22S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1183765/000119312518201030/0001193125-18-201030-index.htm
2018-06-29CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1183765/000119312518209644/0001193125-18-209644-index.htm
2018-07-05424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1183765/000119312518213121/0001193125-18-213121-index.htm
2018-08-03S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1183765/000119312518238248/0001193125-18-238248-index.htm
2018-09-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000119312518277150/0001193125-18-277150-index.htm
2018-09-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1183765/000119312518277590/0001193125-18-277590-index.htm
2018-09-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1183765/000119312518280222/0001193125-18-280222-index.htm
2018-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000119312518280224/0001193125-18-280224-index.htm
2018-09-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1183765/000119312518284805/0001193125-18-284805-index.htm
2018-12-21S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1183765/000119312518356360/0001193125-18-356360-index.htm
2019-01-24S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1183765/000119312519015913/0001193125-19-015913-index.htm
2019-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000119312519020870/0001193125-19-020870-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1183765/000119312519029025/0001193125-19-029025-index.htm
2019-02-1310-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1183765/000119312519037986/0001193125-19-037986-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1183765/000119312519041016/0001193125-19-041016-index.htm
2019-03-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1183765/000119312519092797/0001193125-19-092797-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1183765/000119312519122337/0001193125-19-122337-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000119312519159640/0001193125-19-159640-index.htm
2019-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000119312519252820/0001193125-19-252820-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000119312519293902/0001193125-19-293902-index.htm
2019-11-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1183765/000119312519296638/0001193125-19-296638-index.htm
2019-11-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1183765/000119312519298671/0001193125-19-298671-index.htm
2019-11-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000119312519299253/0001193125-19-299253-index.htm
2019-12-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1183765/000119312519307330/0001193125-19-307330-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000119312519319297/0001193125-19-319297-index.htm
2020-01-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1183765/000119312520018466/0001193125-20-018466-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1183765/000119312520038278/0001193125-20-038278-index.htm
2020-03-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1183765/000119312520072484/0001193125-20-072484-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1183765/000119312520117146/0001193125-20-117146-index.htm
2020-05-07DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1183765/000119312520136213/0001193125-20-136213-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000119312520149374/0001193125-20-149374-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000119312520154383/0001193125-20-154383-index.htm
2020-06-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1183765/000119312520160770/0001193125-20-160770-index.htm
2020-06-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1183765/000119312520162310/0001193125-20-162310-index.htm
2020-06-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1183765/000119312520170426/0001193125-20-170426-index.htm
2020-06-16S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1183765/000119312520170428/0001193125-20-170428-index.htm
2020-06-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1183765/000119312520171065/0001193125-20-171065-index.htm
2020-08-07S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1183765/000119312520212471/0001193125-20-212471-index.htm
2020-08-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1183765/000119312520218955/0001193125-20-218955-index.htm
2020-08-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1183765/000119312520222448/0001193125-20-222448-index.htm
2020-11-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1183765/000119312520284848/0001193125-20-284848-index.htm
2018-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000120919118052147/0001209191-18-052147-index.htm
2018-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000120919118052151/0001209191-18-052151-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000120919120026853/0001209191-20-026853-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000120919120026855/0001209191-20-026855-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000120919120031700/0001209191-20-031700-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000120919120031702/0001209191-20-031702-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000120919120051158/0001209191-20-051158-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000120919120051159/0001209191-20-051159-index.htm
2020-05-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1183765/000138713120004413/0001387131-20-004413-index.htm
2020-09-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1183765/000138713120008393/0001387131-20-008393-index.htm
2018-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1183765/000156459018007268/0001564590-18-007268-index.htm
2018-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1183765/000156459018013451/0001564590-18-013451-index.htm
2018-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1183765/000156459018014920/0001564590-18-014920-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1183765/000156459018021113/0001564590-18-021113-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1183765/000156459018029332/0001564590-18-029332-index.htm
2019-03-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1183765/000156459019010145/0001564590-19-010145-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1183765/000156459019018864/0001564590-19-018864-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1183765/000156459019031497/0001564590-19-031497-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1183765/000156459019043009/0001564590-19-043009-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1183765/000156459020010667/0001564590-20-010667-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1183765/000156459020024390/0001564590-20-024390-index.htm
2020-05-12NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1183765/000156459020024461/0001564590-20-024461-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1183765/000156459020038063/0001564590-20-038063-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1183765/000156459020051635/0001564590-20-051635-index.htm
2019-11-27DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000171369519000008/0001713695-19-000008-index.htm
2019-12-03D/ANotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1183765/000171369519000009/0001713695-19-000009-index.htm
2018-07-03EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1183765/999999999518001697/9999999995-18-001697-index.htm
2020-06-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1183765/999999999520001478/9999999995-20-001478-index.htm
2020-08-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1183765/999999999520002174/9999999995-20-002174-index.htm
2018-06-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1183765/999999999718006577/9999999997-18-006577-index.htm
2019-02-25CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1183765/999999999719000571/9999999997-19-000571-index.htm

Molecular Templates, Inc (MTEM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Molecular Templates, Inc (MTEM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2342%
Institutional Ownership: 8199%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-28Longitude Capital Partners III, LLC10% Share HolderSell2,447.0010.7526,295.710.00https://www.sec.gov/Archives/edgar/data/1183765/000089924320023790/0000899243-20-023790-index.htm
2018-11-26Eric E PomaOfficerBuy152,945.000.4264,236.90152,945.00https://www.sec.gov/Archives/edgar/data/1183765/000089924318029818/0000899243-18-029818-index.htm
2018-09-25Scott D MorensteinDirectorBuy545,454.005.502,999,997.001,559,241.00https://www.sec.gov/Archives/edgar/data/1183765/000089924318025415/0000899243-18-025415-index.htm
2018-12-26CDK ASSOCIATES, L.L.C.DirectorBuy25,000.003.4586,250.001,584,241.00https://www.sec.gov/Archives/edgar/data/1183765/000091957418008210/0000919574-18-008210-index.htm
2019-11-21Scott D MorensteinDirectorBuy468,750.008.003,750,000.002,052,991.00https://www.sec.gov/Archives/edgar/data/1183765/000091957419007463/0000919574-19-007463-index.htm
2018-11-26Eric E PomaOfficerBuy86,951.000.7161,735.21239,896.00https://www.sec.gov/Archives/edgar/data/1183765/000089924318029818/0000899243-18-029818-index.htm
2018-09-21David HirschDirectorBuy365,000.005.502,007,500.003,261,535.00https://www.sec.gov/Archives/edgar/data/1183765/000120919118052147/0001209191-18-052147-index.htm
2018-09-21Longitude Capital Partners III, LLC10% Share HolderBuy365,000.005.502,007,500.003,261,535.00https://www.sec.gov/Archives/edgar/data/1183765/000120919118052151/0001209191-18-052151-index.htm
2019-11-25David HirschDirectorBuy937,000.008.007,496,000.004,198,535.00https://www.sec.gov/Archives/edgar/data/1183765/000089924319028236/0000899243-19-028236-index.htm
2019-11-25Longitude Capital Partners III, LLC10% Share HolderBuy937,000.008.007,496,000.004,198,535.00https://www.sec.gov/Archives/edgar/data/1183765/000089924319028242/0000899243-19-028242-index.htm
2020-10-28TARGET N V BIOTECH10% Share HolderBuy80,000.009.40751,688.005,149,996.00https://www.sec.gov/Archives/edgar/data/1183765/000089924320030364/0000899243-20-030364-index.htm
2020-10-30TARGET N V BIOTECH10% Share HolderBuy80,000.008.83706,312.005,229,996.00https://www.sec.gov/Archives/edgar/data/1183765/000089924320030364/0000899243-20-030364-index.htm
2020-01-03Jason S. KimOfficerBuy54,136.000.4222,737.1254,136.00https://www.sec.gov/Archives/edgar/data/1183765/000089924320000254/0000899243-20-000254-index.htm
2020-09-16KEVIN M. LALANDEDirectorSell500,000.0013.056,525,000.006,097,298.00https://www.sec.gov/Archives/edgar/data/1183765/000120919120051159/0001209191-20-051159-index.htm
2020-09-16SHV Management Services, LLC10% Share HolderSell500,000.0013.056,525,000.006,097,298.00https://www.sec.gov/Archives/edgar/data/1183765/000120919120051158/0001209191-20-051158-index.htm
2020-05-20KEVIN M. LALANDEDirectorSell300,000.0016.514,953,000.006,597,298.00https://www.sec.gov/Archives/edgar/data/1183765/000120919120031702/0001209191-20-031702-index.htm
2020-05-20SHV Management Services, LLC10% Share HolderSell300,000.0016.514,953,000.006,597,298.00https://www.sec.gov/Archives/edgar/data/1183765/000120919120031700/0001209191-20-031700-index.htm